KMB vs XENE · P/E 19, rev $8.35B vs $2.55B cap
Kimberly-Clark Corporation (KMB) versus Xenon Pharmaceuticals Inc (XENE) — a side-by-side from cached financials, not a winner call.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Xenon Pharmaceuticals Inc (XENE) is a biotechnology company listed on US.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Latest reported XENE revenue for 2026-06-30 was $0. Net income was -$213.0M. XENE currently screens at market cap $2.55B.
KMB currently screens at market cap $32.88B and trailing P/E 19.2. XENE currently screens at market cap $2.55B.
Not investment advice. Open the KMB and XENE stock pages for the full models.
Not investment advice.